Interleukin-10 and Cancer

References

• Florentine DF., Bond MW., Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J Exp Med 1989; 170: 2081–2095
   PubMed Web of Science ®Google Scholar
• Suda T, O'Garra A, MacNeil I, et al. Identification of a novel thymocyte growth promoting factor derived from B cell lymphomas. Cell Immunol 1990; 129: 228–240
   PubMed Web of Science ®Google Scholar
• Moore KW., Vieira P, Fiorentino DF., et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRFI. Science 1990; 248: 1230–1234
   PubMed Web of Science ®Google Scholar
• Vieira P, de Waal-Malefyt R, Dang M-N, et al. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL10) cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991; 88: 1172–1176
   PubMed Web of Science ®Google Scholar
• MacNeil I, Suda T, Moore KW., et al. IL-10: A novel cytokine growth cofactor for mature and immature T cells. J Immunol 1990; 145: 4167–4173
   PubMed Web of Science ®Google Scholar
• Baer R, Bankier AT., Biggin MD., et al. DNA sequence and expression of the B95–8 Epstein-Barr virus genome. Nature 1984; 310: 207–211
   PubMed Web of Science ®Google Scholar
• Moore KW., Rousset F, Banchereau J. Evolving principles in im-munopathology: Interleukin 10 and its relationship to Epstein-Barr virus protein BCRFI. Springer Semin Immunopathol 1991; 13: 157–166
   PubMed Web of Science ®Google Scholar
• Niiro H, Otsuka T, Abe M, et al. Epstein-Barr Virus BCRFI gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes. Lymph Cytok Res 1992; 11: 209–214
   PubMedGoogle Scholar
• Go NF., Castle BE., Barrett R, et al. Interleukin 10 (IL-10), a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172: 1625–1631
   PubMed Web of Science ®Google Scholar
• Thompson-Snipes L, Dhar V, Bond MW., et al. Interleukin-10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173: 507–510
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 1992; 10: 785–807
   PubMed Web of Science ®Google Scholar
• Rowe M. Epstein-Barr virus, infection and immunity. 1992; 1: 517–520
   Google Scholar
• Masucci MG., Bejarano MT., Masucci G, et al. Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol 1983; 76: 311–321
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J Immunol 1980; 124: 745–751
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phytohe-magglutinin is inhibited by interferon: The early suppression by T cells of Epstein-Barr virus infection is mediated by interferon. J Immunol 1981; 126: 829–833
   PubMed Web of Science ®Google Scholar
• Hasler F, Bluestein HG., Zvaifler NJ., et al. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med 1983; 157: 173–188
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim Biophys Acta 1988; 948: 263–286
   Web of Science ®Google Scholar
• Gosselin J, Menezes J, Mercier G, et al. Differential intcrleukin-2 and interferon-gamma production by human lymphocyte cultures exceptionally resistant to Epstein-Barr virus immortalization. Cell Immunol 1989; 122: 440–449
   PubMed Web of Science ®Google Scholar
• Fiorentino DF., Zlotnik A, Vieira P, et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Thl cells. J Immunol 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Fiorentino DF., Zlotnik A, Mosmann TR., et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822
   PubMed Web of Science ®Google Scholar
• Hannum CH., Wilcox CJ., Arend WP., et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336–340
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Yssel H, Roncarolo M-G, et al. Interleukin-10. Curr Opin Immunol 1992; 4: 314–320
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, et al. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991; 174: 915–924
   PubMed Web of Science ®Google Scholar
• Macatonia SE., Doherty TM., Knight SC., et al. Differential effect of interleukin 10 on dendritic cell-induced T cell proliferation and interferon-γ production. J Immunol 1992; 150: 3755–3765
   Web of Science ®Google Scholar
• Howard M, O'Garra A, Ishida H, et al. Biological properties of interleukin-10. J Clin Immunol 1992; 12: 239–247
   PubMed Web of Science ®Google Scholar
• Howard M, Muchamuel T, Andrade S, et al. IL-10 protects mice from lethal endotoxemia. J Exp Med 1993; 177: 1205–1213
   PubMed Web of Science ®Google Scholar
• Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705–711
   PubMed Web of Science ®Google Scholar
• Miethke T, Wahl C, Heeg K, et al. T-cell mediated lethal shock triggered in mice by the superantigen staphylococcal entero-toxin B: Critical role of tumor necrosis factor. J Exp Med 1992; 175: 91–98
   PubMed Web of Science ®Google Scholar
• Bean A, Freiberg R, Andrade S, et al. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun, (submitted for publication)
   Web of Science ®Google Scholar
• Harrison DE. Evaluating functional abilities of primitive he-matopoietic stem cell populations. Curr Topics Microbiol Immunol m- 1992; 13–30
   Google Scholar
• Heimfeld S, Hudak S, Weissman I, et al. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci USA 1991; 88: 9902–9906
   PubMed Web of Science ®Google Scholar
• Bartelmez SH., Bradley TR., Bertoncello I, et al. Interleukin-1 plus interleukin-3 plus colony-stimulating factor-1 are essential for clonal proliferation of primitive myeloid bone marrow cells. Exp Hematol 1989; 17: 240–245
   PubMed Web of Science ®Google Scholar
• Ikebuchi K, Ihle JN., Hirai Y, et al. Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin 1, interleukin 6, and granulocyte colony-stimulating factor. Blood 1988; 72: 2007–2014
   PubMed Web of Science ®Google Scholar
• Rennick D, Hunte B, Dang W, et al. IL-10 promotes the growth of megakaryocyte, mast cell and multi-lineage colonies: Analysis with committed progenitors and Thy llo Sea 1+ stem cells. Exp Hematol 1993, (in press)
   Web of Science ®Google Scholar
• Donahue RE., Yang YC., Clark SC. Human p40 T-celi growth factor (interleukin 9) supports erythroid colony formation. Blood 1990; 75: 2271–2275
   PubMed Web of Science ®Google Scholar
• Rennick D, Yang G, Muller SC., et al. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cell. Proc Natl Acad Sci USA 1987; 84: 6889–6893
   PubMed Web of Science ®Google Scholar
• O'Garra A, Chang R, Go N, et al. Ly-1 B (B-1) cells are the main source of B-cell derived IL-10. Eur J Immunol 1992; 22: 711–722
   PubMed Web of Science ®Google Scholar
• O'Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2: 821–832
   PubMed Web of Science ®Google Scholar
• Hardin JA., Vos K, Kawano Y, et al. A function for Ly-1 +B cells. Proc Soc Exp Biol Med 1990; 195: 172–182
   PubMed Web of Science ®Google Scholar
• Anderson KC., Bates MP., Slaghenoupt EL., et al. Expression of human B cell associated antigens on leukemias and lymphomas: A model of human B cell differentiation. Blood 1984; 63: 1424–1433
   PubMed Web of Science ®Google Scholar
• Caligoris-Cappio F, Gobbi M, Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982; 155: 623–628
   PubMed Web of Science ®Google Scholar
• Gurish MF., Ghildyal N, McNeil HP., et al. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med 1992; 175: 1003–1012
   PubMed Web of Science ®Google Scholar
• Ghildyal N, McNeil HP., Stechschulte S, et al. Interleukin-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis infected mice. J Immunol 1992; 149: 2123–2129
   PubMed Web of Science ®Google Scholar
• Ghildyal N, McNeil HP., Gurish MF., et al. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Chem 1991; 267: 8473–8477
   Web of Science ®Google Scholar
• Chen WF., Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528–534
   PubMed Web of Science ®Google Scholar
• Rousset F, Garcia E, Defrance T, et al. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890–1893
   PubMed Web of Science ®Google Scholar
• Defrance T, Vandervliet B, Briere F, et al. Interleukin 10 and transforming growth factor B co-operate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671–682
   PubMed Web of Science ®Google Scholar
• Ishida H, Hastings R, Kearny J, et al. Continuous anti-IL-10 antibody administration depletes mice of CDS B cells but not conventional B cells. J Exp Med 1992; 175: 1213–1220
   PubMed Web of Science ®Google Scholar
• Emilie D, Touitou R, Raphael M, et al. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 1992; 22: 2937–2942
   PubMed Web of Science ®Google Scholar
• Blay JY., Burdin N, Rousset F, et al. Prognostic value of IL-10 in non Hodgkin's lymphoma. Blood 1992; 80(Suppl 1)38a, (abstract)
   Google Scholar